These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34650600)

  • 1. Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma.
    Zhou C; Zhang H; Lu L
    Front Genet; 2021; 12():744113. PubMed ID: 34650600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Front Oncol; 2021; 11():663263. PubMed ID: 34123820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
    Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G
    Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
    Huang S; Li D; Zhuang L; Zhang J; Wu J
    Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
    Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
    Front Genet; 2021; 12():682082. PubMed ID: 34745200
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
    Bai Y; Lin H; Chen J; Wu Y; Yu S
    Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
    Huang S; Zhang J; Lai X; Zhuang L; Wu J
    Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma.
    Wang Y; Li N; Tian D; Zhou CW; Wang YH; Yang C; Zeng MS
    Cancer Manag Res; 2021; 13():6451-6471. PubMed ID: 34429653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Signature of Hepatocellular Carcinoma and Analysis of Immune Infiltration Based on m6A-Related lncRNAs.
    Guo T; He K; Wang Y; Sun J; Chen Y; Yang Z
    Front Oncol; 2021; 11():691372. PubMed ID: 34527575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
    Wang T; Zhou Z; Wang X; You L; Li W; Zheng C; Zhang J; Wang L; Kong X; Gao Y; Sun X
    Front Genet; 2022; 13():929035. PubMed ID: 36081998
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
    Tang P; Qu W; Wang T; Liu M; Wu D; Tan L; Zhou H
    Front Genet; 2021; 12():785185. PubMed ID: 34917132
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma.
    Yuan M; Wang Y; Sun Q; Liu S; Xian S; Dai F; Zhang L; Fan Y; Wang F; Yang D; Zheng Y; Deng Z; Tan W; Liu Y; Cheng Y
    Biomed Res Int; 2021; 2021():9798231. PubMed ID: 33506049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
    Zheng J; Guo J; Cao B; Zhou Y; Tong J
    Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis.
    Wu J; Ren X; Wang N; Zhou R; Chen M; Cai Y; Lin S; Zhang H; Xie X; Dang C; Zhang S; Zhou Z
    Front Genet; 2021; 12():779554. PubMed ID: 34880908
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma.
    Kong W; Wang X; Zuo X; Mao Z; Cheng Y; Chen W
    Front Genet; 2020; 11():1037. PubMed ID: 33101369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients.
    Zheng J; Guo J; Zhu L; Zhou Y; Tong J
    J Ovarian Res; 2021 Sep; 14(1):124. PubMed ID: 34560889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma.
    Chen H; Pan Y; Jin X; Chen G
    Front Oncol; 2021; 11():713346. PubMed ID: 34386428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis.
    Cai D; Zhou Z; Wei G; Wu P; Kong G
    Front Genet; 2022; 13():952369. PubMed ID: 36118856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.